Uveitis following COVID-19 Infection: A Case Series including Vogt-Koyanagi-Harada Disease and Birdshot Chorioretinopathy
Case Reports in Ophthalmology · 2026-08-31 · 17 (1) · 962-970
DOI: 10.1159/cop/acaag006 ↗Abstract
Introduction: Uveitis in the context of COVID-19 is rare, yet a relatively higher frequency of uncommon posterior variants has been described both following COVID-19 infection and after COVID-19 vaccination. In this series, we report 4 cases of new-onset uveitis following a PCR-confirmed COVID-19 infection: 2 cases of incomplete Vogt-Koyanagi-Harada (VKH) disease and 2 cases of birdshot chorioretinopathy (BSCR). Case Presentations: Four patients presented with ocular symptoms and characteristic clinical findings consistent with either VKH disease or BSCR shortly after PCR-confirmed COVID-19 infection. VKH disease and BSCR occurred within 2 weeks of infection and 1 month after infection, respectively. Human leukocyte antigen (HLA) genotyping revealed HLA-A29 in both BSCR cases. One VKH case carried the HLA-DRB1*04:04 allele, indicating possible genetic susceptibility. No relevant medical history was reported, and systemic work-up was negative in all cases. Conclusion: We report the first 2 cases of BSCR in the setting of PCR-confirmed COVID-19 infection, and add 2 cases of COVID-19-associated VKH disease to the existing literature. These observations further support the hypothesis that viral infections may trigger autoimmune uveitic entities. While causality remains to be fully established, COVID-19 should be considered a potential immunological trigger for BSCR, in line with its documented role in VKH disease. Further studies are needed to elucidate the potential role of viral infections in the pathogenesis of BSCR.
EUVIMED